Filter
1176
Filtered Results: 1176
Text search:
poor
immune
function
Featured
Recommendations
143
New Publications
411
Language
Document type
No document type
779
Guidelines
152
Studies & Reports
135
Manuals
56
Strategic & Response Plan
28
Training Material
17
Fact sheets
4
Situation Updates
3
Resource Platforms
1
Infographics
1
Countries / Regions
India
90
Kenya
53
South Africa
50
Global
39
Nigeria
33
Ethiopia
29
Uganda
27
Philippines
24
Liberia
22
Zambia
22
Nepal
21
Tanzania
20
Malawi
19
Africa
18
Sierra Leone
17
Rwanda
17
Bangladesh
17
Namibia
16
Cambodia
13
Lesotho
12
Myanmar / Burma
11
Botswana
10
South–East Asia Region
10
Ghana
9
Indonesia
8
Latin America and the Carribbean
8
Western and Central Europe
8
Zimbabwe
7
Mozambique
7
Pakistan
6
South Sudan
5
Syria
5
Eswatini/ Swaziland
5
Burkina Faso
3
Congo, Democratic Republic of
3
USA
3
Afghanistan
3
Sudan
3
Ukraine
3
East and Southern Africa
3
Asia
3
Eastern Europe
3
Russia
3
Georgia
3
Guinea
2
Somalia
2
Papua New Guinea
2
Benin
2
West and Central Africa
2
Albania
2
Southern Africa
2
Iran
2
Senegal
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Iraq
1
Jordan
1
Germany
1
Lebanon
1
Thailand
1
Gambia
1
China
1
Brazil
1
North Macedonia
1
Greece
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Fiji
1
Laos
1
Tajikistan
1
Vietnam
1
North America
1
Mauritius
1
Tunisia
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
537
Clinical Guidelines
155
Public Health
74
Women & Child Health
68
Key Resources
38
Capacity Building
25
Pharmacy & Technologies
12
Toolboxes
HIV
117
TB
91
Mental Health
50
COVID-19
49
NTDs
41
Rapid Response
37
Planetary Health
37
Caregiver
30
Ebola
25
NCDs
25
AMR
21
Conflict
17
Pharmacy
15
Disability
14
Natural Hazards
12
Refugee
12
Global Health Education
11
Polio
8
Cholera
7
Zika
5
Health Financing Toolbox
4
Social Ethics
3
South Sudan
2
Specific Hazards
2
Revised and expanded version of the Guidelines
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Snakebite is an acute life threatening time limiting medical emergency. It is a preventable public
health hazard often faced by rural population in tropical and subtropical countries with heavy
rainfall and humid climate.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding...
There is growing international consensus that food systems transformation is important to address the challenges of malnutrition in all its forms, the burden of noncommunicable diseases (NCDs), environmental sustainability, increasing inequality and ensuring the welfare of workers and animals. In li...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Around the world, more than 2 billion people lack access to safely managed water, sanitation and hygiene services, with conflicts and climate change exacerbating the issue.
Unsafe and insufficient WASH facilities, especially in rural and remote areas, can lead to increased health complications fo...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
